Trial intelligence / Profile preview

Enzastaurin with Chemotherapy in Advanced NSCLC

NCT00469976Phase 2Withdrawn

Sponsor
Eastern Cooperative Oncology Group
Start
Jun 2007
Modality
Small Molecules
01

Overview

A Phase 2 trial of enzastaurin in non-small cell lung cancer (NSCLC), sponsored by Eastern Cooperative Oncology Group. Planned start Jun 2007; status: withdrawn.

02

Drugs

enzastaurin
03

Conditions

non-small cell lung cancer (NSCLC)

Beyond the preview

Go deeper on NCT00469976.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00469976.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call